Correlation Between Dietary Patterns, Anthropometric Profiles, Genetic Profiles, and Biomarker Levels to Diabetes
Elucidating the Correlation Between Dietary Patterns, Anthropometric Measurements, Genetic Profiles, and Biomarker Levels Related to Diabetes
1 other identifier
interventional
181
1 country
1
Brief Summary
The goal of this clinical trial is to explore the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in diabetes in healthy adults. The primary objective is to examine the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in the context of diabetes. Secondary Objectives:
- To examine the relationship between the diabetes parameters, dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels in the intervention group and control group following a month-long diet.
- To examine the correlation between subjects' characteristics (age, sex, educational background, ethnic background, and economic status) and diabetes parameters
- To examine the correlation between subjects' life habits (exercise, smoking, sleeping) and diabetes parameters
- To examine the compliance of subjects to study intervention
- To examine the progression of anthropometric measurements during the study period
- The process involves identifying changes between markers related to the development of diabetes.
- To develop a risk prediction of diabetes based on dietary intake and health indicators. Hypothesis: There was a correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in the context of diabetes. Participants: One hundred fifty individuals will participate in the study, providing substantial data for analysis. Participants will undergo dietary interventions and biomarker testing (continuous and checkpoint) to establish baseline data for health indicators, specifically diabetes. Three groups of participants will be recruited:
- Case group: Balanced healthy diet group, eating 45-65% of calories from carbohydrates, 20-25% of calories from fat, and 10% from protein.
- Low-carb diet group: an eating pattern with \<45% of total energy provided by carbohydrates. This group will undergo two different meal diets to see changes in blood biomarkers due to specific diet variations.
- Control group: this group will not receive a diet intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2025
CompletedFirst Submitted
Initial submission to the registry
June 16, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedSeptember 2, 2026
September 1, 2026
3 months
June 16, 2026
September 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
HbA1C
will be presented as a percentage.
at enrollment and at the end of treatment in week 4
Fasting glucose
will be presented in mg/dL
at enrollment and at the end of treatment in week 4
Fasting insulin
will be presented in μU/mL
at enrollment and at the end of treatment in week 4
Secondary Outcomes (9)
Body weight
at enrollment and at the end of treatment in week 4
Body mass index
at enrollment and at the end of treatment in week 4
Cholesterol
at enrollment and at the end of treatment in week 4
Low density cholesterol (LDL)
at enrollment and at the end of treatment in week 4
High density cholesterol (HDL)
at enrollment and at the end of treatment in week 4
- +4 more secondary outcomes
Study Arms (3)
balanced, healthy diet
EXPERIMENTALBalanced healthy diet group, eating 45 - 65% of calories from carbohydrates, 20 - 25% of calories from fat, and 10% from protein
a low-carbohydrate diet group
EXPERIMENTALLow-carb diet group, eating pattern with less than 45% of total energy provided by carbohydrates.
Control group
NO INTERVENTIONSubjects in the control group did not receive a special diet, only their dietary intake was monitored.
Interventions
Subjects in the treatment group will be given a balanced diet or low-carb diet based on the amount of carbohydrates given.
Eligibility Criteria
You may qualify if:
- Age between 18-59 years
- Participants must provide informed consent to participate in the study, which include dietary tracking, biometric testing, and adherence to the intervention program.
- Participants must be available for the full duration of the study (one months) and able to comply with the scheduled meal plans and testing appointments.
You may not qualify if:
- Individuals with history of type 1 and 2 diabetes, autoimmune, thyroid disease, which may affect carbohydrate metabolism.
- Individuals who have experienced major surgery in the past six months, as it might impact carbohydrate metabolism and the body's reaction to dietary modifications.
- Individuals with eating disorders, given the potential risks associated with dietary changes and the focus on food intake and biometrics.
- Individuals with allergies or intolerances to the ingredients used in the study's meal plans to prevent adverse health effects and ensure participant safety.
- Individuals currently participating in other clinical trials that could influence the outcomes of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Universitas Trisakti
Jakarta, DKI Jakarta, 11440, Indonesia
Related Publications (2)
Yu EY, Ren Z, Mehrkanoon S, Stehouwer CDA, van Greevenbroek MMJ, Eussen SJPM, Zeegers MP, Wesselius A. Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study. BMC Med. 2022 Nov 21;20(1):450. doi: 10.1186/s12916-022-02653-1.
PMID: 36414942RESULTEsmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007 Mar;85(3):910-8. doi: 10.1093/ajcn/85.3.910.
PMID: 17344515RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 16, 2026
First Posted
September 2, 2026
Study Start
April 28, 2025
Primary Completion
July 16, 2025
Study Completion
September 2, 2025
Last Updated
September 2, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
IPD will not or may not be shared to maintain the confidentiality of subject data.